Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |